Al Dawaa Medical Services Company, listed as 4163 on the Saudi Stock Exchange, is involved in a variety of activities including online wholesale, pharmaceutical agents, and retailing of medical equipment. The company operates through Retail and Wholesale segments, focusing on selling goods to customers through pharmacies and wholesale customers, respectively. Established in 1993, it is headquartered in Al Khobar, Saudi Arabia.
As of the latest data, the stock price of Al Dawaa Medical Services Company closed at 115.60 SAR, with a 52-week range of 70.30 SAR to 117.00 SAR. The company's market capitalization stands at 9.826 billion SAR, and it has a price-to-earnings (P/E) ratio of 30.10. The earnings per share (EPS) reported is 3.84 SAR. Al Dawaa Medical Services Company does not currently pay dividends.
In terms of trading strategy, investors are considering a stop loss at 111 SAR. The target prices are set at 119 SAR, 124 SAR, and 135 SAR, suggesting potential areas of growth or resistance that traders may be watching.
For ongoing and detailed analysis, it is advisable to keep an eye on financial news.
Dr Saud
As of the latest data, the stock price of Al Dawaa Medical Services Company closed at 115.60 SAR, with a 52-week range of 70.30 SAR to 117.00 SAR. The company's market capitalization stands at 9.826 billion SAR, and it has a price-to-earnings (P/E) ratio of 30.10. The earnings per share (EPS) reported is 3.84 SAR. Al Dawaa Medical Services Company does not currently pay dividends.
In terms of trading strategy, investors are considering a stop loss at 111 SAR. The target prices are set at 119 SAR, 124 SAR, and 135 SAR, suggesting potential areas of growth or resistance that traders may be watching.
For ongoing and detailed analysis, it is advisable to keep an eye on financial news.
Dr Saud
Trade active